GlassScriptPhysician profile
Indira L Amato
NPI 1841385424
$831.72
in general payments reported to CMS, 2019-2025
16 companies · $155 in 2025
The $155 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $149 · 2023: $331 · 2024: $197 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $164.48 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $163.52 | 2022-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sanofi Pasteur INC. | $101.53 | 2023-2024 | |
| Kaleo, INC. | $84.45 | 2022-2023 | Auvi-Q |
| Ars Pharmaceuticals Operations, INC. | $64.46 | 2025 | Neffy |
| Ironshore Pharmaceuticals INC. | $44.52 | 2024 | |
| Seqirus USA INC | $31.98 | 2022-2025 | Flucelvax, Fluad |
| Tris Pharma INC | $27.10 | 2022 | |
| Sanofi-Aventis U.S. LLC | $24.74 | 2025 | |
| Hologic Sales and Service, LLC | $22.60 | 2023 | Thinprep 2000 Processor |
| Baxter Healthcare | $20.76 | 2022 | |
| Collegium Pharmaceutical, INC. | $18.19 | 2025 | Jornay Pm |
| Corium, LLC | $17.00 | 2023 | Azstarys |
| Glaxosmithkline, LLC. | $16.12 | 2023 | Bexsero |
| Cranial Technologies, INC | $15.90 | 2024 | Doc Band |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $14.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Indira Amato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.